Literature DB >> 8713002

Compliance problems in paediatric atopic eczema.

G Fischer1.   

Abstract

Compliance problems are a common cause of apparent treatment failure in atopic eczema. The results of a survey of parents with children attending dermatologists for atopic eczema is presented. Major reasons for failure to comply include a poor understanding of the chronic nature of the disease, a fear of topical corticosteroids, the belief that atopic eczema is due to an allergy, and the time and cost of treatment. The explanation that treatment is a control and not a cure is also important in the parent's perception of treatment results. Suggested solutions to some of these points are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8713002     DOI: 10.1111/j.1440-0960.1996.tb01070.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  9 in total

Review 1.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 2.  Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids.

Authors:  Roman Schiffner; Julia Schiffner-Rohe; Michael Landthaler; Wilhelm Stolz
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 3.  Cost of illness of atopic dermatitis in children: a societal perspective.

Authors:  Andrew S Kemp
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey.

Authors:  Maya El Hachem; Francesco Gesualdo; Giampaolo Ricci; Andrea Diociaiuti; Loredana Giraldi; Orsola Ametrano; Corrado Occella; Anna Belloni Fortina; Mirella Milioto; Fabio Arcangeli; Oriana Simonetti; Simona Giancristoforo; Elisabetta Calamelli; Carlo Mazzatenta; Iria Neri
Journal:  Ital J Pediatr       Date:  2017-02-28       Impact factor: 2.638

Review 5.  Comprehensive Approach: Current Status on Patient Education in Atopic Dermatitis and Other Allergic Diseases.

Authors:  Stephan Traidl; Claudia Lang; Peter Schmid-Grendelmeier; Thomas Werfel; Annice Heratizadeh
Journal:  Handb Exp Pharmacol       Date:  2022

6.  TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.

Authors:  Leïla Moret; Emmanuelle Anthoine; Hélène Aubert-Wastiaux; Anne Le Rhun; Christophe Leux; Juliette Mazereeuw-Hautier; Jean-François Stalder; Sébastien Barbarot
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

7.  GPs' experiences of diagnosing and managing childhood eczema: a qualitative study in primary care.

Authors:  Emma Le Roux; Kingsley Powell; Jonathan P Banks; Mathew J Ridd
Journal:  Br J Gen Pract       Date:  2018-01-15       Impact factor: 5.386

8.  Knowledge, Attitude and Advice-Giving Behaviour of Community Pharmacists Regarding Topical Corticosteroids.

Authors:  Wing Man Lau; Parastou Donyai
Journal:  Pharmacy (Basel)       Date:  2017-07-25

Review 9.  Bidirectional relationships between psychological health and dermatological conditions in children.

Authors:  Amy E Mitchell
Journal:  Psychol Res Behav Manag       Date:  2018-07-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.